Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
JAFCO Group is a leading Japanese venture capital firm that operates a specialized investment practice dedicated to the life sciences, biotechnology, and healthcare industries. Established in 1973, the firm provides venture and growth capital to innovative startups developing breakthrough therapeutics, medical devices, and digital health solutions. JAFCO's life science team employs a hands-on investment strategy, offering portfolio companies strategic guidance, business development support, and access to an extensive global network. The firm has a distinguished track record of fostering the growth of the Japanese biotech ecosystem, with numerous portfolio companies successfully reaching IPO or being acquired by major pharmaceutical entities. JAFCO continues to be a key financier for high-potential science-driven ventures across Japan and international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on JAFCO Life Science Investments.